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Postpartum Dysgalactia Syndrome (PDS) represents a considerable health problem of postpartum sows, primarily
indicated by mastitis and lactation failure. The poorly understood etiology of this multifactorial disease necessitates
the use of the porcine mammary epithelial cell (PMEC) model to identify how and to what extent molecular
pathogen defense mechanisms prevent bacterial infections at the first cellular barrier of the gland. PMEC were
isolated from three lactating sows and challenged with heat-inactivated potential mastitis-causing pathogens
Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) for 3 h and 24 h, in vitro. We focused on differential
gene expression patterns of PMEC after pathogen challenge in comparison with the untreated control by performing
microarray analysis. Our results show that a core innate immune response of PMEC is partly shared by E. coli and
S. aureus. But E. coli infection induces much faster and stronger inflammatory response than S. aureus infection.
An immediate and strong up-regulation of genes encoding cytokines (IL1A and IL8), chemokines (CCL2, CXCL1,
CXCL2, CXCL3, and CXCL6) and cell adhesion molecules (VCAM1, ICAM1, and ITGB3) was explicitly obvious
post-challenge with E. coli inducing a rapid recruitment and activation of cells of host defense mediated by IL1B and
TNF signaling. In contrast, S. aureus infection rather induces the expression of genes encoding monooxygenases
(CYP1A1, CYP3A4, and CYP1B1) initiating processes of detoxification and pathogen elimination. The results indicate
that the course of PDS depends on the host recognition of different structural and pathogenic profiles first, which
critically determines the extent and effectiveness of cellular immune defense after infection.Introduction
Postpartum Dysgalactia Syndrome (PDS), with Coliform
Mastitis (CM) as cardinal symptom, is known as a multi-
factorial infectious disease in postpartum sows and a ser-
ious problem with high economic relevance in modern
piglet production worldwide [1]. Significant milk pro-
duction failure and other clinical signs including in-
creased rectal temperature (>39.3 °C) postpartum, loss
of appetite or low water intake, redness and inflamma-
tion of teats, pain, failure to expose teats and nurse, and
sometimes vaginal discharge are typical indicators of
affected animals [2]. While initial research focused on
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1Institute for Genome Biology, Leibniz-Institute for Farm Animal Biology,
Wilhelm-Stahl-Allee 2, D-18196 Dummerstorf, Germany
Full list of author information is available at the end of the article
© 2015 Jaeger et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.PDS, current studies rather concentrate on the role of
causative pathogens, immune defense mechanisms, in-
fection pressure and genetic predisposition. Gram-
negative pathogens, e.g. Escherichia coli (E. coli) and
gram-positive pathogens, e.g. Staphylococcus aureus
(S. aureus) were most commonly isolated from milk of
PDS-positive, but also from non-affected sows [3,4]. The
major question is why only some sows develop subclin-
ical or clinical signs of infection within 12 h to 48 h
postpartum after contact with ubiquitous bacteria while
others remain clinically healthy. Frequency and severity
of this complex disease appear to depend on immune
competence including resistance to infection of the sow.
While the heritability of CM resistance has been esti-
mated in a range from 0.02 up to 0.20 [5], further
genetic studies on mastitis susceptibility are lacking.
Extremely low infectious dose for colonization ofThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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croorganisms [6] abet microbial mammary tissue inva-
sion. In sows as well as in other animal species E. coli
pathogenesis has been associated with lipopolysacchar-
ide (LPS) endotoxin release inducing acute and severe
inflammation [7]. In contrast, mastitis induced by S. aur-
eus infection is mostly characterized as subclinical, mild
and persistent [8]. Pathogenesis of both infections may
proceed to pathogen clearance or to chronic infection
depending on the effectiveness of host defense mecha-
nisms especially at early stages of cellular response [8].
When pathogens have overcome physical barriers and
entered the lumen of the mammary gland through the
teat canal, macrophages and mammary epithelial cells
(MEC) are important for initiating and driving the im-
mediate non-specific innate immune response [9]. In-
flammation response of periparturient sows after
inoculation of porcine mammary gland with different
potential mastitis-causing E. coli strains specified a dom-
inant role of that pathogen species in CM [10]. The de-
velopment of clinical symptoms of CM in the sow was
suggested to be associated with a locally increased pro-
duction of pro-inflammatory cytokines such as interleu-
kin 1-beta (IL1-beta), IL6, IL8, and tumor necrosis
factor-alpha (TNF-alpha) in response to intramammary
E. coli infection [10,11]. Additionally, the time of infec-
tion of the mammary gland relative to parturition and
the number of circulating neutrophils at the time of in-
fection were shown to influence the development of
clinical CM in the sow [12]. No published study was
found regarding the inflammatory response of peripar-
turient sows after inoculation of mammary gland with
S. aureus. But it was commonly shown that E. coli and
S. aureus are also the main causative agents of bovine
mastitis, the most economically important disease of
dairy ruminants. Comparative kinetic studies on infected
udder of cows and inoculation of primary bovine mam-
mary epithelial cells (pbMEC) with E. coli and S. aureus
showed that E. coli swiftly and strongly induced the ex-
pression of cytokines and bactericidal factors, while
S. aureus elicited a retarded response and failed to
quickly induce the expression of bactericidal factors [8].
Both pathogens induced similar patterns of immune re-
sponse genes, but the host response to E. coli was ob-
served to be much faster and stronger than that to
S. aureus infection [8]. Also different expression profiles
of upstream as well as downstream regulators of early
responses of pbMEC to E. coli and S. aureus may con-
tribute to the different clinical manifestations and out-
come of mastitis caused by these two pathogens [13].
Except for few referred studies on pathogen defense
mechanisms of porcine mammary glands, the role of
porcine mammary epithelial cells (PMEC) in the initi-
ation of the innate immune response remains largelyunknown. Our study focused on inflammatory response
mechanisms of PMEC, isolated from lactating sows, after
challenge with potential mastitis-causing pathogens such
as E. coli and S. aureus. Strains from both pathogens
used in our study were isolated from milk of PDS-
positive sows. The molecular characterization of affected
signaling pathways and involved signaling molecules in
PMEC dependent on challenge time was performed by
microarray analysis. Similarities and differences in the
response of PMEC to both heat-inactivated pathogen
species were determined by comparing the expression
profile between the pathogen-challenged PMEC groups
and unchallenged control as well as among the chal-
lenged groups. Selective analysis of most and strongest
affected molecular and cellular functions, canonical
pathways, upstream regulators and signaling networks
were performed to throw light on the role of PMEC in
pathogen clearance after bacterial invasion. Our results
may especially improve the understanding of the specific
reaction of PMEC to pathogen challenge and may help
to get insight in how and to what extent environmental
bacteria trigger inflammatory and immune responses in
porcine mammary gland in general. To our knowledge,
this is the first microarray-based study investigating gen-
etic factors that determine the initial immune response
of PMEC in vitro, at 3 h and at 24 h post-challenge
(hpc) with heat-inactivated E. coli and S. aureus strains,
potentially causing mastitis of sows.
Materials and methods
Cell culture and pathogen challenge
Primary cell cultures were established from mammary
glands of three lactating sows of commercial herds. Ani-
mal care and tissue collection was performed in compli-
ance with the German Law of Animal Protection. The
experimental protocol was approved by the Animal Care
Committee of the Leibniz-Institute for Farm Animal
Biology, Dummerstorf, Germany. Tissues from eight
mammary complexes cranial of the navel were collected
aseptically immediately after slaughter from each individ-
ual. Subsequently, tissue samples were washed in Hank’s
Balanced Salt Solution (HBSS, PAN Biotech, Aidenbach,
Germany) containing 17 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES, PAN Biotech) and
2% Antibiotic/Antimycotic Solution (APS, 10 000 U/mL
penicillin, 10 mg/mL streptomycin sulphate, 25 μg/mL
amphotericin B, PAA, Cölbe, Germany). After a second
washing step, tissue samples were finely minced using
sharp blades and placed in 15 mL falcon tubes. Washing
steps were repeated until the supernatant was clear. Tissue
digestion steps were performed in collagenase solution
(Type III, 200 U/mL, Biochrom, Berlin, Germany) at 37 °C
for 45 min. Occasionally, digested tissue was mixed
with washing buffer and filtered through stainless
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Steinheim, Germany) to remove undissociated tissue
and debris. Cells were collected by centrifugation at
1000 rpm and 15 °C for 10 min and pellets were re-
suspended in washing buffer without APS. This step was
repeated until the supernatant was clear (3–4 digestion
steps in total). At the end, cell pellets were resuspended
in complete medium consisting of Dulbecco’s Modified
Eagle Medium/Nutrient Mixture F-12 (DMEM/F12,
PAN Biotech), 10% fetal bovine serum (FBS, PAA), 1%
APS, 10 μg/mL insulin (Sigma-Aldrich) and 1 μg/mL
hydrocortisone (Sigma-Aldrich). Primary cells were cryo-
preserved in 90% FBS and 10% dimethyl sulfoxide
(DMSO, Carl Roth, Karlsruhe, Germany). Before starting
the experiments, cells were thawn, plated onto collagen-
coated (1:10 collagen R in destilled water, Menal,
Emmendingen, Germany) 10 cm petri dishes and cul-
tured in complete medium for several days at 37 °C and
5% CO2 in a humidified atmosphere. Fibroblasts, adipo-
cytes and other cell types were removed by selective tryp-
sinization (Trypsin/EDTA (0.25%/0.02%, Sigma-Aldrich)
during the following days. These cell types detach more
rapidly from plastic after trypsinization than do the epi-
thelial cell islands. The culture was quickly rinsed with
growth medium to stop the enzymatic dispersion and to
remove the fibroblastic cell areas. The relatively undis-
turbed epithelial cell islands were further incubated with
growth medium. This procedure was repeated several
times until a uniform and confluent monolayer of epithe-
lial cells was formed.
Staphylococcus aureus (not characterized) and E. coli
(gMEc240, sequence type 101, phylogroup B1, C+)
strains used for this experiment were isolates from milk
of PDS-positive sows. Both strains were grown in brain-
heart-infusion-broth (BHB, Oxoid, Wesel, Germany)
at 37 °C to the logarithmic phase of culture growth
(Optical Density at 600 nm [OD600] 0.5, ~ 5 × 10
7/mL).
Dilution series were plated to calibrate cell counts from
the OD readings. Heat-inactivation of bacteria was per-
formed at 80 °C for 1 h and verified by control plating.
Afterwards, bacteria were spun down at 3000 rpm for
15 min, washed twice with DMEM/F12 medium and re-
suspended herein at a density of 1 × 108/mL. Aliquots
were stored at −20 °C.
Approximately 4.4 × 105 of the isolated PMEC from
each individual (three biological replicates) were seeded
and cultured in collagen-coated 6-well plates in com-
plete medium without APS (three technical replicates
per individual and treatment condition). On the next
day, medium was changed. Forty eight hours after seed-
ing, cells reached 90% confluency. PMEC were chal-
lenged with 107/mL heat-inactivated S. aureus and
E. coli, respectively, for 3 h and for 24 h (Figure 1A).
Equivalent challenge treatments have been considered asrobust cell stimulation based on previously published re-
ports. After incubation periods, pathogen-challenged and
unchallenged cells (control) were washed three times
with phosphate buffered saline (PBS, PAA) to remove the
bacteria. Cells were collected for total RNA isolation.
Immunocytochemistry/microscopy
PMEC were seeded on 12 mm coverslips (Carl Roth) in
24-well plate (Biochrom) at a density of 10 000 cells/well.
After two days of culturing, medium was discarded,
and coverslips were washed twice with PBS and fixed
with ice-cold methanol (−20 °C, Carl Roth) for
20 min. Cells were permeabilized with 0.2% Triton
X-100 (Carl Roth), diluted with PBS for 5 min and
washed twice with PBS. Non-specific binding sites
were blocked by incubating the coverslips with 10%
FBS in PBS for 30 min at room temperature. Cover-
slips were washed twice with PBS and incubated with
mouse anti-cytokeratin 18-fluorescein isothiocyanate
(anti-Cy18-FITC, Sigma-Aldrich) and mouse anti-alpha-
smooth muscle actin antibodies (clone 1A4, Sigma-
Aldrich), respectively in a humidified chamber for 1 h.
Coverslips were washed three times with PBS. Bound
anti-alpha-smooth muscle actin antibody was visualized
by 1 h incubation of the coverslips with goat anti-
mouse FITC-labeled secondary antibody (Sigma-Aldrich).
Nuclei of the cells were stained with 4’,6-diamidino-2-
phenylindole (DAPI, Carl Roth) for 15 min. Coverslips
were washed twice with PBS, air dried and mounted
with 1,4-diazabicyclo[2.2.2]octane (DABCO) on glass
slides (both from Carl Roth). Coverslips were analyzed
by immunofluorescence microscopy (Microphot-FXA,
Nikon, Düsseldorf, Germany).
RNA extraction, target preparation, and hybridization
Total RNA was isolated using the TRI® reagent (Sigma-
Aldrich) according to the manufacturer’s instructions.
Isolated RNA was purified using RNeasy Mini Kit
(Qiagen, Hilden, Germany), and contaminating DNA
was removed by DNase I digestion (Qiagen). RNA integ-
rity and quantity were checked by agarose gel electro-
phoresis and by spectrometry with a NanoDrop ND1000
spectrophotometer (PEQLAB, Erlangen, Germany). Ab-
sence of DNA contamination was verified by PCR of the
porcine beta-actin gene (forward primer, GAGAAG
CTCTGCTACGTCGC, reverse primer, CCTGATGTC
CACGTCGCACT, Promega, Mannheim, Germany) with
isolated RNA as templates. For the microarray analysis
individual biotin-labeled cRNA was synthesized by the
Gene Chip 3’ Express Kit (Affymetrix, Santa Clara, CA,
USA). cRNA was fragmented (~100 bp) and hybridized
for 16 h at 45 °C to Affymetrix Gene Chip® Porcine
Genome Arrays. The microarrays were scanned using
GeneChip Scanner 3000 (Affymetrix). Raw data was
Figure 1 Schema of experimental setting. (A) Confluent PMEC cultures were challenged with 107/mL heat-inactivated S. aureus and E. coli,
respectively, for 3 h and 24 h. In parallel unchallenged control cells were cultivated. After incubation periods, cells were collected and total RNA
was isolated. (B) PMEC isolated from three lactating sows represent three biological replicates. Three technical replicates were analysed of each
challenge (S. aureus, E. coli), unchallenged control and the two challenge times (3 h, 24 h), respectively. A total of 45 microarrays were obtained.
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(accession number: GSE64246).
Microarray data analysis
A microarray experiment was conducted in triplicate;
three biological replicates were performed for each bac-
terial strain and experimental condition (3 h, 24 h, and
control). A total of 45 microarrays were analysed
(Figure 1B). Five experimental groups were built, includ-
ing cells challenged with E. coli (3 hpc and 24 hpc), cells
challenged with S. aureus (3 hpc and 24 hpc) and un-
challenged control cells. Data pre-processing was done
using Bioconductor/ R packages. After quality control
[16], background correction and data normalization
were performed using GC-RMA (Log2). To improve
statistical power [17], inappropriate probe sets were ex-
cluded from further analysis due to three criteria:
(i) probe sets absent in >50% of PMEC culture within
each experimental group (MAS5 filtering); (ii) probe sets
with a small standard deviation (SD < 0.2); (iii) probe
sets with a small mean value (M < 2.5). A mixed-model
analysis was performed using statistical analysis soft-
ware (SAS, SAS Institute, Cary, NC, USA) to deter-
mine relative changes in mRNA levels, including
effects mediated by experimental group and individual
animal [Vij = μ + experimental groupi + animalj + eij]. Cor-
responding q-values were calculated to estimate the pro-
portion of false positives among all significant hypotheses
and thus to correct for multiple testing [18]. Alterations
in transcript abundances were considered to be statisti-
cally significant at p < 0.05 and q < 0.05. Subsequently,data was filtered by fold change (FC < −1.5; FC > 1.5).
The Ensembl gene annotation (Sus scrofa 9) was used as
previously described [19]. A principal component ana-
lysis (PCA) was performed in R to assess an overall trend
about the gene expression data and inspection about
outliers. Gene lists from microarray results (Additional
files 1, 2, 3 and 4) were evaluated with Ingenuity Pathway
Analysis (IPA, Ingenuity Systems, Redwood City, CA,
USA) to identify most affected molecular and cellular
functions, canonical pathways, upstream regulators, and
functional networks (p ≤ 0.05, Fisher’s exact test).
Real-time quantitative PCR
First strand cDNA synthesis was performed with the
same RNA samples used for the microarray analysis
applying SuperScript III MMLV reverse transcriptase
(Invitrogen, Karlsruhe, Germany) in a reaction con-
taining 1 μg RNA, 500 ng oligo (dT)13VN primer
and 500ng random hexamer primers (Promega) accord-
ing to the manufacturer’s protocol. Real-time quantitative
PCR (RT-qPCR) was performed in duplicate to validate
the differential expression results. Quantification of
mRNA copy numbers was performed on a LightCycler
480 System using the LightCycler 480 SYBR Green I
Master (all Roche Applied Science). Sequences of the
oligonucleotide primers used (Sigma-Aldrich) and ampli-
cons are given in Additional file 5. The reaction condi-
tions for PCR were as follows: initial denaturation step at
95 °C for 5 min and 45 cycles consisting of denaturation
at 95 °C for 10 s, annealing at 60 °C for 15 s and extension/
fluorescence acquisition at 72 °C for 25 s. Melting curve
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after completion of the qPCR run to confirm specificity
of the amplification and absence of primer dimers.
Threshold cycles were converted to copy numbers using
a standard curve generated by amplifying serial dilutions
of an external PCR-generated standard (108–102 copies).
The calculated copy numbers were normalized with a
factor derived from expression of the reference genes
HPRT1 and RN7SK according to the method described
by Vandesompele et al. [20]. Significance of differences
was assessed with ANOVA. The results were declared to
be statistically significant at p < 0.05. Spearman’s Rank
Correlation was used to compare microarray and RT-
qPCR measurements using the SAS 9.3 software (SAS
Institute, Inc., Cary, NC, USA).
Results
Morphological characterization of PMEC cultures
Heterogeneous population of epithelial, fibroblast-like,
and adipose cells isolated from mammary glands of
lactating sows were purified by continuous removal of
non-epithelial cells by trypsin/EDTA treatment. Fibro-
blastic cells detached from their substratum, while epi-
thelial cells were found to be more resistant. Most of the
PMEC had a typical cobblestone shape and were con-
nected tightly, visualized by phase contrast microscopy
(Figure 2A). The purity of PMEC cultures was deter-
mined by immunocytochemistry. Cytokeratin elements
of the PMEC cytoskeleton were stained with specific
anti-cytokeratin-18 antibody. Almost all of the cells in
our primary cell cultures were positive for cytokeratin-
18 staining (~97%) confirming high purity of luminal
epithelial cells (Figure 2B). Some cells were found nega-
tive for cytokeratin-18 staining, but positive for alpha-
smooth muscle actin staining (~3%) with a specific anti-
body showing that only few myoepithelial cells wereFigure 2 Validation of cell types in PMEC cultures. (A) Phase contrast m
tissue culture dishes demonstrating typical epithelial cobblestone morphol
were stained with anti-cytokeratin-18 antibody (anti-Cy18, green fluorescenc
cells were stained with anti-smooth muscle actin antibody (anti-Actin, greenpresent in our PMEC cultures (Figure 2C). The homo-
geneity of our established PMEC cultures ensures clarity
and reproducibility of the subsequent experimental
results.
PMEC respond more prominently and earlier to challenge
with E. coli than to challenge with S. aureus
Gene expression profiling of PMEC from three lactating
sows was performed at 3 hpc and at 24 hpc with E. coli
and S. aureus, respectively, in comparison with unchal-
lenged control cells using Affymetrix Gene Chip®
Porcine Genome Arrays. Filtering of raw data based on
MAS5 algorithm and variability of expression of probe
sets revealed 8494 probe sets for further analysis. A prin-
cipal component analysis (PCA) showed that PMEC
biological replicates were distantly clustered indicat-
ing individual differences, but had some similarity
and reproducibility within the five experimental groups
(Additional file 6). These were clustered into three dis-
tinct coloured groups (green dots: control; red dots:
E. coli-challenge; blue dots: S. aureus-challenge) accord-
ing to the density and consisting of three technical repli-
cates, respectively. It was also shown that gene
expression diverged most significantly with increasing
challenge time (3 h to 24 h). No outliers were detected.
Further data analysis showed that more genes were dif-
ferentially expressed at 24 h compared to 3 h after patho-
gen challenge, and following challenge with E. coli
compared to challenge with S. aureus (Figures 3A-D).
Significant expression changes of 156 and 1250 genes
were observed at 3 hpc and at 24 hpc with E. coli, re-
spectively. The expressions of 73 and 1073 genes were al-
tered at 3 hpc and at 24 hpc with S. aureus, respectively.
Approximately 50% of the genes which were differentially
expressed at 3 hpc with S. aureus also differed at 3 hpc
with E. coli (Figure 3E). But 85% of the genes which wereicrograph of a confluent PMEC monolayer grown on collagen-coated
ogy (bar = 100 μm). (B) Dominant luminal mammary epithelial cells
e; nuclei, DAPI, blue fluorescence). (C) Sporadically found myoepithelial
fluorescence; nuclei, DAPI, blue fluorescence).
Figure 3 Significantly differentially expressed genes comparing E. coli-challenged and S. aureus-challenged PMEC. (A, B) More genes
were differentially expressed at 24 h than at 3 h after pathogen challenge, and following challenge with E. coli than challenge with S. aureus.
(C-F) Venn diagrams showing numbers of differentially expressed genes as a function of time and pathogen stimulus vs. untreated PMEC
(control) of three independent biological replicates; p < 0.05, q < 0.05, −1.5 > FC > 1.5. The numbers in the intersections represent the genes
differentially expressed in the two groups. The early response of PMEC to both pathogen species (3 hpc, E) was followed by a late, more
intensive host response (24 hpc, F).
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regulated at 3 hpc with S. aureus (Figure 3E). The early
response of PMEC to both pathogen species (3 hpc) was
followed by a late more intensive host response (24 hpc)
as indicated by an 8-fold and 14-fold increase of differen-
tially expressed genes at 24 hpc with E. coli and S. aureus,
respectively (Figures 3A-D). However, the number of
shared up- and down-regulated genes was increased up
to a maximum of 80% at 24 hpc with both pathogen spe-
cies (Figure 3F).
Molecular and cellular functions predominantly affected
in PMEC by E. coli and S. aureus are different at 3 h, but
similar at 24 h post-challenge
Top five categories of molecular and cellular functions
which were affected in PMEC at 3 hpc and at 24 hpc
with E. coli or S. aureus were identified using Ingenuity
Pathway Analysis (IPA) software (Table 1). At 3 hpc withE. coli, most of the differentially expressed genes in
PMEC were categorized by functions comprising “gene
expression”, “cellular movement”, “cellular growth and
proliferation”, “cellular development”, and “cell death
and survival”. Except for the two first named categories,
all other molecular and cellular functions are also af-
fected in cells at 24 hpc with E. coli. Additionally, at the
same time, differentially expressed genes associated with
“RNA post-transcriptional modification” and “cell cycle”
were affected by challenge with E. coli. In contrast, at
3 hpc of PMEC with S. aureus, most differentially
expressed genes were categorized by functions compris-
ing “small molecule biochemistry”, “drug metabolism”,
“lipid metabolism”, “vitamin and mineral metabolism”,
and “energy production”. Genes belonging to these
functional categories were also affected at 3 hpc with
E. coli, but were not predominantly involved in the
early response of PMEC to this pathogen as well as
Table 1 Molecular and cellular functions affected in PMEC
by pathogen challenge
3 h E. coli-challenged vs.
unchallenged control cells
p-value #Molecules
Gene Expression 1.72E-14 - 1.71E-04 46
Cellular Growth and Proliferation 3.56E-14 - 3.13E-04 55
Cellular Development 1.46E-13 - 3.95E-04 52
Cell Death and Survival 1.29E-11 - 3.95E-04 50
Cellular movement 4.13E-11 - 3.95E-04 40
3 h S. aureus-challenged vs.
unchallenged control cells
p-value #Molecules
Small Molecule Biochemistry 4.30E-08 - 4.53E-03 14
Drug Metabolism 2.15E-07 - 4.53E-03 8
Lipid Metabolism 2.15E-07 - 4.53E-03 11
Vitamin and Mineral Metabolism 2.15E-07 - 3.39E-03 4
Energy Production 8.97E-07 - 2.27E-03 4
24 h E. coli-challenged vs.
unchallenged control cells
p-value #Molecules
Cellular Growth and Proliferation 1.46E-15 - 5.35E-03 255
RNA Post-Transcriptional Modification 3.21E-14 - 4.88E-03 53
Cell Cycle 1.46E-12 - 4.88E-03 115
Cell Death and Survival 7.44E-10 - 5.09E-03 226
Cellular Development 4.90E-08 - 5.35E-03 219
24 h S. aureus-challenged vs.
unchallenged control cells
p-value #Molecules
RNA Post-Transcriptional Modification 9.24E-15 - 1.62E-02 42
Cell Cycle 8.61E-10 - 1.62E-02 95
Cellular Growth and Proliferation 8.88E-10 - 1.37E-02 202
Cell Death and Survival 4.29E-08 - 1.62E-02 187
Gene Expression 3.25E-07 - 6.69E-03 156
Top five categories of molecular and cellular functions affected in PMEC at 3 h
and at 24 h post-challenge with E. coli and S. aureus, respectively, compared
with unchallenged control cells with their respective p-value and number of
molecules included in each class obtained from IPA software.
Table 2 Up-regulated canonical pathways in PMEC at 3 hpc
E. coli-challenged vs. unchallenged control cells
Canonical pathway (Genes involved in pathway) p-value







Agranulocyte Adhesion and Diapedesis
(CXCL3,IL1A,VCAM1,ICAM1,CCL2,CLDN1,CXCL1,CXCL2,CXCL6)
4.92E-08
Hepatic Fibrosis/Hepatic Stellate Cell Activation
(CXCL3,IL1A,VCAM1,ICAM1,CCL2,IFNAR2,IL1RAP,IFNAR1)
8.20E-08
Role of IL-17A in arthritis
(CXCL3,NFKBIA,CCL2,CXCL1,CXCL6)
2.43E-06
S. aureus-challenged vs. unchallenged control cells
Canonical pathway (Genes involved in pathway) p-value
Bupropion Degradation 3.44E-06
Acetone Degradation I (to Methylglyoxal) 3.86E-06
Estrogen Biosynthesis 1.11E-05
Nicotine Degradation III 2.87E-05
Melatonin Degradation I
(CYP1A1,CYP3A4,CYP1B1 are involved in all five canonical
pathways)
3.39E-05
Top five categories of up-regulated canonical pathways in PMEC at 3 hpc with
E. coli and S. aureus, respectively, compared with unchallenged control cells
with their respective p-value and genes involved in each pathway obtained
from IPA software.
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and S. aureus.
Similar late response effects in terms of most affected
with molecular and cellular functions comprising “RNA
post-transcriptional modification”, “cell cycle”, “cellular
growth and proliferation” and “cell death and survival”
were apparent in PMEC at 24 hpc with E. coli and
S. aureus, respectively, compared with unchallenged
control cells. In contrast, differentially expressed genes
associated with “cellular development” or “gene expres-
sion” were most affected by long-term challenge (24 h)
with E. coli and S. aureus, respectively. Overall, PMEC
are more responsive to the challenge with E. coli than
S. aureus as early as 3 hpc and as late as 24 hpc in term
of the number of differentially expressed genes involved
in molecular and cellular functions (243 vs 41 at 3 hpc;
868 vs 682 at 24 hpc, see also Table 1).Genes of different canonical pathways are involved in
response of PMEC to pathogen challenge dependent on
pathogen species and incubation time
At 3 hpc, IPA analysis identified 250 canonical pathways
affected by the challenge with E. coli compared to 170
pathways by S. aureus. After long-term challenge (24 h)
of PMEC with E. coli or S. aureus 295 and 267 canonical
pathways were affected, respectively.
The most prominent genes which were significantly
up-regulated in PMEC at 3 hpc with E. coli encode pro-
inflammatory cytokines and chemokines (chemokine
(C-C motif ) ligand 2, CCL2; chemokine (C-X-C motif ) li-
gands CXCL1, CXCL2, CXCL3, and CXCL6; interleukin
1 alpha, IL1A), cell adhesion proteins (vascular cell adhe-
sion molecule 1, VCAM1; intercellular adhesion mol-
ecule, ICAM1; integrin beta 3, ITGB3), and interferon
signaling proteins (interferon-induced protein with tetra-
tricopeptide repeats, IFIT1 and IFIT3; interferon recep-
tors, IFNAR1 and IFNAR2) responsible for pathogen
recognition by granulocytes and the first line of host
defense against bacterial infection (Table 2).
Consistent with the up-regulation of the metabolism
and degradation of various substrates (bupropion, ace-
tone, nicotine, and melatonin) and estrogen biosynthesis
in PMEC at 3 hpc with S. aureus, the most represented
up-regulated genes involved in these canonical pathways
are cytochrome P450, family 1, subfamily A, polypeptide 1
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genases (Table 2).
Furthermore, most of the significantly up-regulated ca-
nonical pathways, which were identified in PMEC at 3 hpc
with E. coli were also up-regulated at 24 hpc with E. coli
(Tables 2 and 3). For example, “interferon signalling” was
also one of the top up-regulated canonical pathways in
PMEC at 24 hpc with S. aureus (Table 3).
In addition, at 24 hpc of PMEC with E. coli genes in-
volved in inflammatory response signaling pathways such
as “HMGB1 signaling” were significantly up-regulated,
and at 24 hpc with S. aureus genes regulating cell growth,
proliferation, apoptosis and activation of natural
killer cells were significantly up-regulated (Table 3).
Genes encoding growth factors (bone morphogenic pro-
tein 2, BMP2 and BMP4) as well as different transcription
factors (FBJ murine osteosarcoma viral oncogene homolog,
FOS; jun proto-oncogene, JUN; vav3 guanine nucleotide
exchange factor, VAV3; early growth response 1, EGR1)Table 3 Up-regulated canonical pathways in PMEC at
24 hpc
E. coli-challenged vs. unchallenged control cells




















S. aureus-challenged vs. unchallenged control cells


















Top five categories of up-regulated canonical pathways in PMEC at 24 hpc
with E. coli and S. aureus, respectively, compared with unchallenged control
cells with their respective p-value and genes involved in each pathway
obtained from IPA software.involved in BMP, IL-2 and TGF-beta signaling pathways
are significantly down-regulated at 3 hpc with E. coli
(Table 4). “Differential regulation of cytokine production in
macrophages and T helper cells by IL-17A and IL-17 F”
and “MIF regulation of innate immunity” are some of the
top five significantly down-regulated canonical pathways,
critically involved in early response (3 hpc) of PMEC to
challenge with S. aureus and which are different from early
response (3 hpc) of the cells to E. coli (Table 4). The most
prominent down-regulated genes, which are involved in al-
most all of these pathways, encode transcription factor
FOS and the cytokines colony stimulating factor 2 (CSF2)
and CXCL1.
Canonical pathways regulating cell cycle and protein
ubiquitination are some of the top five significantly
down-regulated canonical pathways, which were mostly
affected in PMEC at 24 hpc with E. coli as well as at
24 hpc with S. aureus (Table 5). Genes involved in these
pathways encode heat shock proteins (DnaJ (Hsp40)
homolog, subfamily C, member 9, DNAJC9; DNAJC11;
DnaJ (Hsp40) homolog, subfamily A, member 1,Table 4 Down-regulated canonical pathways in PMEC at
3 hpc
E. coli-challenged vs. unchallenged control cells











T Cell Receptor Signaling
(FOS,JUN,NFKBIA,VAV3)
2.84E-04
PKCq Signaling in T Lymphocytes
(FOS,JUN,NFKBIA,VAV3,MAP3K8)
4.80E-04
S. aureus-challenged vs. unchallenged control cells
Canonical pathway (Genes involved in pathway) p-value
Differential Regulation of Cytokine Production in
Macrophages and T Helper Cells by IL-17A and IL-17 F
(CXCL1,CSF2)
1.75E-04
Role of Tissue Factor in Cancer
(EGR1,CXCL1,JAK2,CSF2)
2.35E-04
Differential Regulation of Cytokine Production in
Intestinal Epithelial Cells by IL-17A and IL-17 F
(CXCL1,CSF2)
2.88E-04
IL-17A Signaling in Gastric Cells
(FOS,CXCL1)
3.42E-04
MIF Regulation of Innate Immunity
(FOS,PTGS2)
9.24E-04
Top five categories of down-regulated canonical pathways in PMEC at 3 hpc
with E. coli and S. aureus, respectively, compared with unchallenged control
cells with their respective p-value and genes involved in each pathway
obtained from IPA software.
Table 5 Down-regulated canonical pathways in PMEC at
24 hpc
E. coli-challenged vs. unchallenged control cells









Adenine and Adenosine Salvage I
(PNP)
5.89E-04
Phosphatidylglycerol Biosynthesis II (Non-plastidic)
(GPAM,ABHD5,PTPMT1,MBOAT2)
6.36E-04
Cell Cycle: G1/S Checkpoint Regulation
(E2F4,CCNE1,CCND2,TFDP1,E2F1,GNL3,CDK2)
7.40E-04
S. aureus-challenged vs. unchallenged control cells
Canonical pathway (Genes involved in pathway) p-value


















Top five categories of down-regulated canonical pathways in PMEC at 24 hpc
with E. coli and S. aureus, respectively, compared with unchallenged control
cells with their respective p-value and genes involved in each pathway
obtained from IPA software.
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HSPA1B; heat shock 70 kDa protein 6, HSPA6; heat
shock 105 kDa/110 kDa protein 1, HSPH1), cell cycle
and cell growth regulating proteins (cell division cycle
23, CDC23; ubiquitin-conjugating enzyme E2S, UBE2S;
ubiquitin-conjugating enzyme E2R2, UBE2R2) and ubi-
quitin specific peptidases (USP34, USP46) (Table 5).
“iNOS signalling” is one of the top five shared canon-
ical pathways, which was affected at 3 hpc with E. coli
and S. aureus, respectively (data not shown), indicating
the production of radical effectors of the innate immune
system to eliminate invading pathogens. The top five
shared canonical pathways, which were affected at
24 hpc with the respective pathogens, include Janus kin-
ase 2 (JAK2), insulin-like growth factor 1 (IGF-1) and
signal transducer and activator of transcription 3
(STAT3) signaling indicating the activation of cytokine-
mediated immune response and regulatory effects on cell
proliferation, apoptosis and migration (data not shown).Different upstream regulators are involved in response of
PMEC to the challenge with E. coli or S. aureus
Using IPA, we considered the top five upstream regula-
tors when comparing pathogen challenged vs. unchal-
lenged PMEC. We found considerable overlap in the
identity and direction of activation of these upstream
regulators between the compared data sets.
“IL1B” (interleukin-1 beta), “lipopolysaccharide”, “IRAK4”
(interleukin-1 receptor-associated kinase 4), “TNF” (tumor
necrosis factor) and “cycloheximide” are the top five up-
stream regulators during the early response (3 hpc) of cells
to E. coli (Table 6). In contrast, at 3 hpc of cells with S. aur-
eus, “beta-estradiol”, “ESR1” (estrogen receptor 1), “U0126”
(1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] buta-
diene), “3-methylcholanthrene” and “paclitaxel” are the top
five upstream regulators associated with host-pathogen
interaction (Table 6). While upstream regulators of the
early response (3 hpc) of PMEC to E. coli and S. aureus are
completely different from another, at 24 hpc with the re-
spective pathogen species, “RAF1” (proto-oncogene serine/
threonine-protein kinase 1) and “PD98059” (2’-Amino-3’-
methoxyflavone) were involved in both host-pathogen in-
teractions. Furthermore, “IKBKB” (inhibitor of kappa light
polypeptide gene enhancer in B-cells, kinase beta),
“TGFB1” (transforming growth factor beta 1), “HGF” (hep-
atocyte growth factor) and “E2F1” (E2F transcription factor
1), “TP53” (tumor protein p53), “INSR” (insulin receptor)
were considered as the top upstream regulators in PMEC
at 24 hpc with E. coli and S. aureus, respectively (Table 6).
The identified transcriptional upstream regulators affect
the observed gene expression patterns after pathogen
stimulation and control the complex cellular response
mechanisms e.g. proliferation, apoptosis, migration and cell
cycle progression to fine-tune the innate immune response
of PMEC (Table 6).
Different genes are involved in “inflammatory response”
of PMEC challenged with E. coli or S. aureus
With particular focus on differentially expressed genes
annotated by IPA as signaling molecules involved in
“inflammatory response”, heatmaps were generated to
illustrate the details of the defense mechanisms of PMEC
to challenge with E. coli or S. aureus.
Our data show that more inflammatory response genes
were up- and down-regulated at 24 h than at 3 h after
pathogen challenge, and following challenge with E. coli
than challenge with S. aureus (Figures 4A and B). In the
early inflammatory response (3 hpc) of the cells to E. coli
40 genes were involved, mainly encoding cytokines,
enzymes, transcription regulators and transmembrane
receptors (Figure 4A). Most of these genes were up-
regulated (maximum FC 6.68) rather than down-
regulated (minimum FC −1.84). Only nine inflammatory
response genes were affected at 3 hpc of the cells with
Table 6 Upstream regulators and their biological functions




IL1B (proinflammatory; proliferation; differentiation;
apoptosis)
6.80E-23
lipopolysaccharide (increase of TLR4 expression;
innate immune response)
8.75E-22
IRAK4 (activation of NF-kB; innate immune response) 6.93E-21
TNF (proinflammat.; proliferation; differentiation;
apoptosis; lipid metabolism; coagulation)
1.17E-20
cycloheximide (inhibitor of protein synthesis;
apoptosis, cell death)
3.04E-20




beta-estradiol (proliferation; growth; apoptosis;
breast cancer signaling)
1.20E-10
ESR1 (growth; proliferation; transcription;
transactivation)
2.00E-09






paclitaxel (antimitotic; apoptosis; growth; survival;
cell viability)
2.55E-08




PD98059 (inhibitor of MAP kinase kinase; apoptosis;
proliferation; migration)
1.98E-11
IKBKB (activation of NF-kB; apoptosis; proliferation) 8.45E-11
TGFB1 (proliferation; differentiation; adhesion;
migration; apoptosis; growth)
1.47E-10
RAF1 (activation of MEK1/2; apoptosis; proliferation;
differentiation; cell cycle; migration)
1.90E-10
HGF (activation of tyrosine kinases; migration;
proliferation; scattering; apoptosis; growth)
9.20E-10




RAF1 (activation of MEK1/2; apoptosis; proliferation;
differentiation; cell cycle; migration)
2.30E-09
E2F1 (apoptosis; proliferation; cell cycle) 3.32E-08
TP53 (tumor suppressor; apoptosis; cell cycle;
growth; proliferation)
3.45E-07
INSR (proliferation; growth; differentiation; migration;
mitogenesis)
9.61E-07
PD98059 (inhibitor of MAP kinase kinase; apoptosis;
proliferation; migration)
1.24E-06
Top five categories of upstream regulators and their functions in PMEC at 3
hpc and at 24 hpc with E. coli and S. aureus, respectively, compared with
unchallenged control cells with their respective p-value of overlap in each
class obtained from IPA software.
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were up- and down-regulated (maximum FC 3.38; mini-
mum FC −2.17) and most of them encode enzymes, cy-
tokines and transcription regulators. Four out of the
nine genes affected by challenge with S. aureus were also
affected by challenge with E. coli.In the late inflammatory response (24 hpc) of the cells
to E. coli 70 genes were involved, mainly encoding en-
zymes, cytokines, transmembrane receptors, transcription
regulators and kinases (Figure 4B). Equal amounts of these
genes were up- and down-regulated (maximum FC 7.87;
minimum FC −2.51). In contrast, only 17 inflammatory
response genes were affected at 24 hpc of the cells with
S. aureus, mainly encoding enzymes, kinases, transmem-
brane receptors, transcription regulators and G-protein
coupled receptors (Figure 4B). Moreover, equal amounts
of these genes were up- and down-regulated (maximum
FC 2.38; minimum FC -4.28). Eleven of the 17 genes
involved in late inflammatory response of the cells to
S. aureus were also affected by challenge with E. coli.
Gene network analysis revealed different key molecules
regulating defense mechanisms of PMEC against E. coli
and S. aureus
Gene interactions were examined using IPA based on the
known contributions of genes to regulatory networks in
order to identify key regulators of the specific immune
response of PMEC to pathogen challenge. The analysis was
focused on the top 50 up-regulated and the top 50 down-
regulated genes at 3 hpc and at 24 hpc with E. coli and
S. aureus. Figure 5 shows that the networks of key regula-
tory genes associated with host response to challenge with
E. coli are more complex than that of challenge with
S. aureus. Especially at 3 hpc with E. coli a wider range of
cytokines and growth factors were induced (Figure 5A)
compared to 3 h challenge with S. aureus (Figure 5B). Our
results indicated key regulatory functions of IL1A, CXCL2,
NFKBIA, mitogen-activated protein kinase kinase kinase 8
(MAP3K8), JUN, FOS and EGR1 within a network consist-
ing of 32 response genes of PMEC at 3 hpc with E. coli. In
contrast, a network consisting of 14 response genes at 3
hpc with S. aureus was created with CSF2, prostaglandin-
endoperoxide synthase 2 (PTGS2), FOS and EGR1 as key
regulators. Furthermore, CXCL1, CYP1B1, dual specificity
phosphatase 6 (DUSP6), FOS and EGR1 were affected in
PMEC at 3 hpc with both pathogens.
Tumor necrosis factor (ligand) superfamily, member 10
(TNFSF10), NFKBIA, and FOS were found to be key reg-
ulators within a network consisting of 22 response genes
at 24 hpc of PMEC with E. coli (Figure 5C). In contrast,
a network consisting of 17 response genes at 24 hpc with
S. aureus was created with CSF2, FOS and prolifera-
ting cell nuclear antigen (PCNA) as key regulators
(Figure 5D). VCAM1, MAP2K6, CYP1B1, leucyl-tRNA
synthetase (LARS), proteasome activator subunit 3
(PSME3), CDC6 and FOS were affected in PMEC at
24 hpc with both pathogens. Almost all of the named
key regulatory genes, which were involved in defense
mechanisms of PMEC against E. coli and S. aureus are
categorized by IPA as genes of “inflammatory response”.
Figure 4 Differentially expressed genes associated with “inflammatory response” in PMEC after pathogen challenge. Heat maps show
differentially expressed genes annotated by IPA and grouped according to their maximal altered mRNA concentrations as well as a function of
challenge time (red, up-regulated; green, down-regulated; fold changes are given inside the boxes). (A) More genes were affected at 3 hpc (early
response) with E. coli (40 genes) than with S. aureus (9 genes). (B) The majority of differentially expressed genes of PMEC was also involved in late
response (24 hpc) to challenge with E. coli (70 genes) than to challenge with S. aureus (17 genes). Gene functions according to the IPA annotation
are given to the right. The affected inflammatory response genes encoding cytokines (C), enzymes (E), kinases (K), transcription regulators (TR),
transmembrane receptors (TMR), transporter (T), growth factors (GF), ligand-dependent nuclear receptors (L-NR), peptidases (P), phosphatases (Ph),
G-protein coupled receptors (G-R) and ion channel proteins (IC).
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In order to validate the microarray experiment, eight se-
lected key transcripts encoding cytokines (IL1A, CXCL2,
CCL2, TNFSF10, and CSF2), kinase (MAP3K8), tran-
scription regulator (NFKBIA) and transmembranereceptor (VCAM1) associated with “inflammatory re-
sponse” were analysed by RT-qPCR (Additional file 7).
Between microarray and RT-qPCR data the correlation
coefficients were highly significant and ranged between
0.84 and 0.98 for the selected genes. The RT-qPCR data
Figure 5 Most highly rated networks of genes triggered in PMEC after pathogen challenge. Network analysis was performed with top 50
up-regulated and top 50 down-regulated genes at 3 hpc and at 24 hpc with E. coli and S. aureus, respectively, and calculated by IPA. The
down-regulated genes are in grey. (A) The gene interaction network of the early response (3 hpc) to E. coli was dominated by IL1A, NFKBIA,
MAP3K8, JUN, FOS and EGR1. (B) CSF2, PTGS2, FOS and EGR1 are the key regulatory genes of the early response (3 hpc) to S. aureus. (C) The
gene interaction network of the late response (24 hpc) to E. coli was dominated by TNFSF10, NFKBIA and FOS. (D) CSF2, FOS and PCNA are
the key regulatory genes of the late response (24 hpc) to S. aureus.
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with a good reproducibility.
Discussion
This study aimed to examine details about signaling
pathways and key signaling molecules involved in PMEC
defense mechanisms against pathogen infection which
can help to elucidate the contribution of PMEC in
pathogenesis of PDS in postpartum sows. To our know-
ledge, this is the first report describing the transcrip-
tional response of PMEC at 3 hpc and at 24 hpc with
heat-inactivated E. coli and S. aureus, in vitro.
However, it is difficult to compare the infection pres-
sure of in vitro to in vivo situations. Therefore, we per-
formed our experiments with heat-inactivated bacteria
to provide standardized experimental conditions. In the
PMEC model, the time course of the pathogen-specific
immune response is well-defined and bacteria concen-
trations are constant throughout the entire experiments.
This is to avoid bacterial overgrowth and depletion of
nutrients during experiments. Since in vivo different cell
types contribute to the immune response of the porcine
mammary gland and the individual variation is high,
PMEC model is less complex and therefore useful to
describe molecular mechanisms of host-pathogen in-
teractions with good reproducibility. We keep in mind
that the PMEC model does not properly reflect the
mastitis-induced regulation of chemokines and the
complement system in the gland. Also the function of
heat-labile proteins during inflammatory response may
not be displayed in the PMEC model. Our study con-
sists of a small number of biological replica, which
might limit the statistical power, but the variability of
pathogen-induced gene expression between biological
cell culture replicates seems to be much less than that
between pigs itself.
It is known that gram-negative (E. coli) and gram-
positive (S. aureus) bacteria have relatively different
structural and pathogenic profiles causing a similar,
but time-delayed pattern of shock in the host [21].
The major pathogenic protein of gram-negative bac-
teria is the cell wall component LPS [22]. In contrast,
gram-positive bacteria express cell wall-associated and
secreted proteins (e.g., protein A, hemolysins, and
phenol-soluble modulin) and cell wall components (e.g.,
peptidoglycan and alanylated lipoteichoic acid) which
have been shown to be inflammatory [23]. While intra-
mammary infection by E. coli is acute in nature and gen-
erally clears within a few days [24], infection by S. aureus
is often less severe but results in a chronic infection that
can persist for a life time of an animal [8]. The reasons
for these pathogen-related differences in the host
immune defense might reside in factors contributing to
the innate immune system [25]. Innate recognition ofpathogen-associated molecular patterns (PAMP) is medi-
ated by evolutionary conserved pattern recognition re-
ceptors (PRR) [26]. For example, TLR2 recognizes cell
wall components of gram-positive bacteria [27], whereas
TLR4 recognizes LPS from gram-negative bacteria [28].
A simultaneous recognition of different pathogens is also
possible, although the type of signal and co-receptor may
differ. TLR2 mRNA expression was shown to be higher
in porcine mammary glands after inoculation with E. coli
as well as in sows that developed clinical signs of mastitis
than in the non-inoculated mammary glands of sows that
remained clinically healthy [9]. However, in our study, we
did not observe significant changes in TLR expression of
PMEC after both pathogen challenges.
Main effects on molecular and cellular functions of PMEC
after pathogen challenge depend on different initial host
defense mechanisms
The initial response of PMEC to the challenge with
E. coli was more prominent than with S. aureus. During
the long infection procedure (24 hpc), a more intense
host response with a maximum increase of shared up-
and down-regulated genes was identified after challenge
with both pathogens. This is in accordance with obser-
vations by Günther et al. [8], who described that S. aur-
eus elicits a much weaker and slower immune response
in primary bovine mammary epithelial cells (pbMEC)
than E. coli. To explain these, we focused on affected
molecular and cellular functions in PMEC after patho-
gen challenge. While short-term as well as long-term
challenge of PMEC with E. coli affected genes which are
mostly involved in cellular processes such as growth,
proliferation, development, death, survival, movement,
and gene expression, short-term challenge with S. aureus
rather induced metabolism of small molecules, lipids,
vitamins and minerals. This is in line with the stud-
ies by Foster [29], who described that S. aureus cyto-
toxicity mainly depends on proteases, hyaluronidases,
lipases, and nucleases which facilitate tissue destruction,
membrane-damaging toxins that cause cytolytic effects in
host cells, and superantigens which contribute to symp-
toms of septic shock. At 24 hpc of PMEC with the re-
spective pathogens, the most affected molecular and
cellular functions are more analog, for example the post-
transcriptional modification of RNA, cell cycle, growth,
proliferation, death, and survival. This is in agreement
with other transcriptional profiling studies which have
demonstrated that immune competent cells respond to
bacterial stimuli with common transcriptional activation
program which can be interpreted as generic “alarm
signals” for infection [30,31]. Both, cell death and lipid
metabolism were found to be among the most significant
molecular functions altered in proteins of cows infected
with either E. coli or S. aureus [32].
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different canonical pathway mediators
Our analysis of most affected canonical pathways and
genes involved in that pathways in PMEC after pathogen
challenge revealed that E. coli induced an early innate
immune response at 3 hpc indicated by a strong up-
regulation of genes encoding pro-inflammatory cyto-
kines and chemokines such as CCL2, CXCL1, CXCL2,
CXCL3, CXCL6, IL1A, and IL8 as well as cell adhesion
proteins such as VCAM1, ICAM1, and ITGB3. The up-
regulation of cytokine production by epithelial cells is a
key component of the host innate immune response
[33]. Cronin et al. [34] reported that TLR4 on cells of
the immune system of cow bind to LPS which in turn
stimulates the secretion of the pro-inflammatory cyto-
kines IL1B and IL6, and the chemokine IL8. The mono-
kine IL1A was first appreciated as an endogenous
pyrogen and lymphocyte-activating factor [35]. The NF-
kappaB-mediated secretion of the chemotactic factor IL8
and TLR-induced expression of vascular endothelial
adhesion molecules promote the rapid recruitment and
activation of immune cells including neutrophils, macro-
phages, lymphocytes and monocytes at the site of in-
flammation which kill invading bacteria [36-38]. These
correlate well with our findings that the induced adhe-
sion and activation of granulocytes, agranulocytes and
stellate cells by PMEC at 3 hpc and at 24 hpc with E. coli
were significant. In contrast, only stellate cell activation
is one of the top five canonical pathways, which was af-
fected at 24 hpc of PMEC with S. aureus. Therefore, we
suggest the early activation of cytokines and of cells of
the innate immune system as critical factors driving the
different downstream cascades of host defense mecha-
nisms. Interferons play also an important role in the first
line of defense of PMEC against E. coli indicated by the
up-regulation of IFN signaling genes IFIT1 and IFIT3 as
well as type I IFN receptor genes such as IFNAR1 and
IFNAR2, which are expressed by leukocytes. An up-
regulation of this gene cluster was also present at 24 hpc
with E. coli as well as at 24 hpc with S. aureus. The
higher up-regulation of chemokines that target mono-
nuclear leukocytes by LPS than by S. aureus culture
supernatant is likely to be related to the differential
activation of the type I IFN pathway, and could in-
duce a different profile of the initial recruitment of
leukocytes [13].
The enhanced gene expression of IL-17A in PMEC at
3 hpc with E. coli is a sign for antibacterial activity of
the cells as well, mediated by indirect enhancement of
neutrophil migration and secretion of cytokines and che-
mokines to infected tissue. With regard to the innate im-
mune response to infection, IL-17A was found in milk
cell RNA extracts in the early phase (8 hpc) of the in-
flammatory response [39] as well as in milk leukocytesfrom cows suffering from S. aureus mastitis [40,41]. In
contrast, IL-17A signaling pathways were down-
regulated in PMEC at 3 hpc with S. aureus. Genini et al.
[31] stated that the comparison of E. coli and S. aureus
infections in cattle in vivo reveals affected genes showing
opposite regulation with the same altered biological
functions and this provides evidence that E. coli can
cause a stronger host response. Gilbert et al. [13] sug-
gested that E. coli induces a more intense response asso-
ciated with strong NF-kappaB stimulation and the
recruitment of a wider repertoire of immune cells,
whereas S. aureus interferes with cell DNA integrity and
may induce a more restricted immune response involv-
ing the IL-17A pathway. In contrast to the short-term
challenge of PMEC with E. coli, at 3 hpc with S. aureus
we observed a strong up-regulation of CYP1A1, CYP3A4
and CYP1B1 encoding monooxygenases, which have piv-
otal roles in primary and secondary metabolic pathways
and are involved in the detoxification and elimination of
reactive oxygen species and other poisonous compounds
[42,43]. Thus, as expected canonical pathways including
different metabolic degradation processes as well as
estrogen biosynthesis were mostly affected in PMEC at
3 hpc with S. aureus. Genes encoding the cell adhesion
molecules VCAM1 and ITGB3 were also up-regulated in
PMEC at 3 hpc and at 24 hpc with S. aureus. This can
lead to an induction of infiltration of immune cells to
the site of infection to act there as key factors in the host
defense against invading pathogens [44]. These differ-
ences in the initial innate immune response of PMEC to
E. coli or S. aureus are consistent with studies in mam-
mary epithelial cells from cows and sheep where it was
argued that the response of mammary epithelial cells
(MEC) to S. aureus was not the result of an overwhelm-
ing cytotoxicity, because the early response was an in-
crease of the reduction activity [8,45]. This may also
explain a very rapid increase in somatic cell count (SCC)
in bovine milk during E. coli infection compared to a
slower but longer increase in S. aureus infections [46].
In general, most of the canonical pathways such as inter-
feron signaling and the activation of immune competent
cells, which were up-regulated in PMEC at 3 hpc with
E. coli were also up-regulated at 24 hpc with E. coli
and, to a lesser extent, at 24 hpc with S. aureus.
Additionally, at the same challenge time High-Mobility-
Group-Protein B1 (HMGB1) signaling is induced by E. coli
suggesting an activation of antigen-presenting dendritic
cells [47]. Insulin-like growth factor 1 (IGF-1) signaling
was induced in PMEC at 24 hpc with S. aureus indicating
an induction of SCC. It was reported that the concentra-
tion of IGF-1 and the numbers of SCC in milk of cows
were greatly elevated in secretions of quarters affected by
acute clinical as well as subclinical mastitis compared with
the corresponding clinically healthy quarters [48]. The
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thereby properly contribute to a decrease of milk produc-
tion in mastitis [49]. In our probe sets the expressions of
both, pro- and anti-apoptotic genes, were modulated in
PMEC, especially at 24 hpc with both pathogens.
Fine-tuning of host defense mechanisms is important for
preventing host cell damage
While a robust and rapid initiation of the host defense
mechanism is essential for a successful pathogen clear-
ance during the acute phase, on the other hand an ex-
cessive but ineffective immune defense can produce
temporary or permanent damage of the host. Therefore,
a restriction of an exuberant innate immune response is
necessary to limit host defense. We observed an in-
creased expression of genes encoding immune dampen-
ing factors such as NF-kappaB pathway suppressors
IkappaB-alpha (NFKBIA) which function in the cyto-
plasm to sequester NF-kappaB, and the kinase MAP3K8
[30,50] at 3 hpc and at 24 hpc of PMEC with E. coli, but
not with S. aureus. Both, NF-kappaB and MAPK cas-
cades are induced by myeloid differentiation primary re-
sponse 88 (MyD88) which is activated by LPS [51]. In
agreement with our results, an increased expression of
NFKBIA was also reported at 4 h after infusion of LPS
into mouse mammary glands [52]. The panel of immune
suppressors in PMEC was extended by increased expres-
sion of TNFAIP8 at 24 hpc with E. coli which functions
in a negative feedback loop regulating TLR-ligand and
TNF-induced responses [53]. Besides, the up-regulation
of anti-inflammatory genes as well as the down-
regulation of pro-inflammatory genes balances the host
immune response. For example, at 3 hpc with S. aureus,
we observed a down-regulation of CXCL1 and the cyto-
kine CSF2 (also known as GM-CSF) in PMEC, which is
contrary to challenge with E. coli. Proteins encoded by
both genes are known to control the production, differ-
entiation and recruitment of neutrophils and macro-
phages [54,55]. Neutrophils from cows affected by
subclinical mastitis demonstrated a significant delay of
apoptosis as compared with neutrophils obtained from
healthy cows and were unresponsive to GM-CSF [56].
Gilbert et al. [13] observed an induction of CXCL1
and CSF2 at 3 hpc and at 6 hpc of bovine mammary
epithelial cells (bMEC) with E. coli crude LPS, but
not with S. aureus culture supernatant. Down-regulation
of these genes could be a result of steroid hormones (e.g.
glucocorticoid), which orchestrate physiological pro-
cesses such as metabolism, immunity and development
and suppress cytokines, adhesion molecules and inflam-
matory response proteins as well as the recruitment of
leukocytes to allow a systemic response to external
stresses and resources [57]. This is in congruence with
our transcriptome analysis of PMEC highlighting steroidhormone (estrogen) biosynthesis as one of the most
enriched canonical pathways at 3 hpc with S. aureus.
Networks of specific pathogen-affected upstream and
downstream regulators associated with inflammatory
response emphasize the complexity of the innate immune
response of PMEC
The activation of downstream signal transduction path-
ways via phosphorylation, ubiquitination, or protein-
protein interactions, ultimately culminate in activation
of transcription factors regulating the expression of
genes involved in inflammation and antimicrobial host
defenses [58]. Our results are in agreement with that,
showing a down-regulation of genes encoding heat-
shock proteins which are involved in protein ubiqui-
tination pathways in PMEC at 24 hpc with E. coli as
well as with S. aureus, and contributing to a decreas-
ing receptor-mediated activation of the innate immune
response.
Nevertheless, the common transcriptional response of
PMEC to both pathogens is characterized by expression
changes of genes interacting in activation, regulation and
limitation of the innate immune response. Upstream
analysis of genes mostly affected in PMEC at 3 hpc with
E. coli are associated with TLR4-mediated recognition of
LPS and downstream signaling cascades involving IL1B,
interleukin-1 receptor-associated kinase 4 (IRAK4) and
TNF to initiate local and systemic inflammatory re-
sponse. This is in accordance with the study of Günther
et al. [8], who reported that genes that are exclusively
and most strongly up-regulated by E. coli may be clus-
tered into a regulatory network with TNF-alpha and IL1.
An association between clinical mastitis and local pro-
duction of IL1-beta, IL6 and TNF-alpha is suggested in
mammary glands of sows [26]. IL1-beta is found in
greater concentration in milk of E. coli mastitis than
in milk of S. aureus mastitis, and TNF-alpha is found
in bovine milk in case of E. coli but not S. aureus mas-
titis [40,59]. In contrast, upstream regulation of the in-
nate immune response of PMEC at 3 hpc with S. aureus
is mediated for example by beta-estradiol, known to
regulate the innate immunity by suppressing the secre-
tion and/or expression of pro-inflammatory mediators
by human uterine epithelial cells, but also stimulates the
production of antimicrobials [60]. Different upstream
regulators affected in PMEC at 24 hpc with E. coli and
with S. aureus have similar functions by controlling gene
expressions involved in the cell division cycle, apoptosis,
cell differentiation, cell adhesion, cell migration and me-
tabolism. This reflects the complexity of the innate im-
mune response of PMEC to the respective pathogens.
The networks of key regulatory genes associated with
host response of PMEC challenged with E. coli are more
complex than that challenged with S. aureus. Almost all
Jaeger et al. Veterinary Research  (2015) 46:50 Page 16 of 18of the key regulatory genes involved in the defense
mechanisms against E. coli and S. aureus are categorized
by IPA as genes of “inflammatory response”. IL1A,
CXCL2, TNFSF10, NFKBIA and MAP3K8 are the main
key regulatory genes of the innate immune response of
PMEC challenged with E. coli, which act on gene expres-
sion of JUN, FOS and EGR1, while challenge with S. aur-
eus mostly affected gene expression of FOS, EGR1 and
PCNA via CSF2 and PTGS2 signaling. Apart from the
different mostly affected genes encoding proteins which
act in several cell-to-cell communications or cytoplasmic
protein interactions, their effects on regulation of tran-
scription centered to the active down-regulation of some
immediate early genes (EGR1, JUN, FOS) executing dis-
tinct biological functions.
Our results show that PMEC do not only pose a physical
barrier against extracellular pathogens, but are immune
competent as well. They are capable of recognizing invad-
ing pathogens and initiate local and systemic immune re-
sponses. The extent and the course of the infection
depend on: (i) pathogen stimuli; (ii) pathogen recognition
and (iii) immune status of the animal. Individual differ-
ences in one of these objects critically influence the innate
host immune response and PDS pathogenesis. The much
faster and stronger inflammatory response of PMEC to
challenge with E. coli results from immediately induced
IL1B and TNF signaling initiating the rapid mobilization
of immune cells mediated by various cytokines and che-
mokines. In contrast, such strong and rapid effects on ex-
pressions of immune relevant genes are not elicited by
challenge with S. aureus, which rather affected metabolic
pathway signaling resulting in a more moderate innate im-
mune response.
Overall, our results suggest PMEC as a suitable mechan-
istic model, which especially contributes the understand-
ing of pathogenesis of porcine mastitis induced by E. coli
or S. aureus, and generally confirm comprehensive expres-
sion patterns of innate immune response in other cell
types as well as animal species. Further comparative inves-
tigations on these gene expression patterns of the innate
immune response of PDS-negative and PDS-positive sows
may aid elucidation of the PDS etiology.Additional files
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